| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC4406 | Rg-102240 | Gene switch ligand as a transcription inducer for use in induceable gene expression systems |
|
| DCC4407 | Rg7388-tco | Highly Potent Clickable Probe for Cellular Imaging of MDM2 and Assessing Dynamic Responses to MDM2-p53 Inhibition |
|
| DCC4408 | Rgb-286147 | Potent, selective & ATP-competitive inhibitor of Cdks |
|
| DCC4409 | Rgd-mimetic-1 | Novel avß6 selective arginyl-glycinyl-aspartic acid (RGD)-mimetic, demonstrating to bind with extremely high affinity and selectivity for the alphavß6 integrin and having the potential as a clinical tool and therapeutic for investigating the role of avß6 |
|
| DCC4410 | Rgd-ss-ca | Novel peptide-drug conjugate, inducing significant tumor growth suppression with negligible toxicity |
|
| DCC4411 | rgh-237 | Orally active, selective dopamine D3 receptor partial agonist |
|
| DCC4412 | Rgia-5524 | Novel Potent and Stable Antagonist of the Human α9α10 Nicotinic Acetylcholine Receptor for the Treatment of Neuropathic Pain |
|
| DCC4413 | rh01617 | Potent inhibitor of Kv1.5 potassium channel |
|
| DCC4414 | Rh02007 | Novel inhibitor of the human papillomavirus (HPV) E6 oncoprotein |
|
| DCC4415 | Rh-5849 | Novel Insect growth regulator, as potential insecticide to control olive fruit fly (Bactrocera oleae Rossi) |
|
| DCC4416 | Rhizoxin | Potent tubulin assembly and cancer cell growth inhibitor |
|
| DCC4417 | Rhlr Agonist S4 | Quorum sensing modulator as a RhlR agonist |
|
| DCC4418 | Rhlr Antagonist 30 | Novel potent and selective RhlR antagonist, strongly inhibiting biofilm formation, and reducing production of virulence factors in P. aeruginosa |
|
| DCC4419 | Rhlr Antagonist E22 | Quorum sensing modulator as a RhlR antagonist |
|
| DCC4420 | rhm-138 | Selective sigma-2 ligand, inducing apoptosis in EMT-6 breast cancer cells |
|
| DCC4421 | Rhodblock 1a | Potent inhibitor of the Rho pathway |
|
| DCC4422 | Ricasetron | Selective antagonist of the serotonin 5-HT3 receptor |
|
| DCC4423 | Rifametane | Antibiotic for tuberculosis (TB) treatment |
|
| DCC4424 | Rifamycin Sv | Natural antibiotic, inhibiting prokaryotic DNA-dependent RNA synthesis and protein synthesis; blocking RNA-polymerase transcription initiation, modulating ß2m aggregation |
|
| DCC4425 | Rilmazafone | Water-soluble benzodiazepine prodrug, as a sedative and hypnotic neuropsychiatric agent |
|
| DCC4426 | Rilpivirine Hydrochloride | HIV-1 reverse transcriptase inhibitor, also acting as an EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor |
|
| DCC4427 | R-imeglimin | Novel antidiabetic agent, impairing glucose uptake by muscle tissue, excessing hepatic gluconeogenesis, and increasing beta-cell apoptosis |
|
| DCC4428 | Rinoxiab | Natural inducer of apoptosis by significantly upregulating Bcl-2, mitigating expression of Bcl2 in HCT 15 cells and attenuating the apoptotic markers and cell cycle regulatory proteins |
|
| DCC4429 | Rip2-in-3 | First-in-Class Receptor Interacting Protein 2 (RIP2) Kinase Specific inhibitor |
|
| DCC4430 | Ripk2 Protac 20 | Novel IAP-based selective RIPK2 degrader |
|
| DCC4431 | Rivoglitazone Hydrochloride | Novel peroxisome proliferator-activated receptor gamma (PPARgamma) agonist |
|
| DCC4432 | Rjr-2403 Fumarate | Highly selective α4β2 subtype nicotinic receptor agonist |
|
| DCC4433 | Rjw100 | Novel potent Liver Receptor Homolog-1 (LRH-1) modulator |
|
| DCC4434 | Rk-0404678 | Novel inhibitor of dengue virus NS5 RNA-dependent RNA polymerase (RdRp), inhibiting the DENV type 2 (DENV2) RdRp activities |
|
| DCC4435 | Rk-682 | Natural selective inhibitor of protein tyrosine phosphatases (PTPases) |
|
